Results 261 to 270 of about 2,388,646 (309)
Some of the next articles are maybe not open access.

Zimt als Inhibitor der Speichelamylase

Lebensmittelchemie, 2022
D. Beranek   +3 more
openaire   +1 more source

Targeting FUS-ALS aggregation with Proteasome Inhibitors

Summary ALS, Amyotrophic lateral sclerosis, a devastating neurodegenerative disease (ND) with no cure, is often caused by abnormal cytosolic aggregation of RNA-binding proteins, the most well-known of which are TDP-43 and FUS. The proteasome is considered one of the major systems that degrades misfolded, including ND-associated ...
Amal Younis   +10 more
openaire   +1 more source

PARP-Inhibitor wirksamer als Chemo?

InFo Hämatologie + Onkologie, 2022
openaire   +1 more source

Proteasome Inhibitors in the Treatment of Multiple Myeloma and AL Amyloidosis

2014
Therapeutic advances in the last decade have led to improved outcomes for people diagnosed with multiple myeloma (MM) and primary systemic (AL) amyloidosis. Foremost among these advances is the incorporation of proteasome inhibitors (PIs) and immunomodulatory drugs (IMiDs) into treatment regimens. Induction regimens for MM which incorporate one or both
openaire   +1 more source

Influence of Inhibitors on the Corrosion of Al and Al-composites in Chloride-containing Solutions - A Review

Korean Journal of Materials Research, 2022
Neeraj Kumar   +3 more
openaire   +1 more source

Screening and development of corrosion inhibitors for al alloys

2015
O objectivo deste trabalho foi procurar/pesquisar de forma sistemática os efeitos da corrosão em estruturas metálicas e ligas, bem como a protecção das mesmas a este fenómeno. Devido às suas propriedades específicas (baixa densidade e boa resistência mecânica) e aplicações práticas em áreas como a aeronáutica, as ligas de alumínio foram os materiais ...
openaire   +1 more source

Neuartiger Inhibitor als letzte Option?

InFo Hämatologie + Onkologie, 2019
openaire   +1 more source

Home - About - Disclaimer - Privacy